RevOpsis Therapeutics
PrivateLast Round
VC Round
Sep 16, 2025
Total Funding Raised
$18.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RevOpsis Therapeutics is a biopharmaceutical company that develops multispecific antibody treatments for complex diseases, with an initial focus on retinal vascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RevOpsis Therapeutics Comparables
Compare RevOpsis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tavo Biotherapeutics | 84% | |
| AsclepiX Therapeutics | 83% | |
| INGENIA Therapeutics | 82% | |
RevOpsis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 16, 2025 | ||||
| Grant | Oct 15, 2024 | ||||
| Seed | Apr 25, 2024 |
RevOpsis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Eye Institute (NIH) | Grant |
| NIH RADx | Grant |
| National Eye Institute | Grant |
| ExSight Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 134% MoM, reaching 1.5K.
- Apr 21, 2026
Monthly visitors grew 351% MoM, from 227 to 1K.
RevOpsis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RevOpsis Therapeutics's valuation, stock price, and market status.